Luna Diabetes Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$23.6M
- Investors
-
7
Luna Diabetes General Information
Description
Manufacturer of an automated insulin delivery system designed for overnight use by insulin pen users. The company's platform delivers micro-boluses during sleep without a traditional pump, enabling users to stabilize nighttime glucose, reduce sleep disruptions, and improve daily blood sugar control through a simple, non-intrusive device.
Contact Information
Website
www.lunadiabetes.comCorporate Office
- 1815 West 13th Street
- Suite 5
- Wilmington, DE 19806
- United States
Corporate Office
- 1815 West 13th Street
- Suite 5
- Wilmington, DE 19806
- United States
Luna Diabetes Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series A1) | 12-Aug-2025 | $23.6M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Luna Diabetes Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 12,390,624 | $0.000100 | 8% | $0.89 | $0.89 | 1x | $0.89 | 24.13% |
Luna Diabetes Patents
Luna Diabetes Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250135109-A1 | Medication fluid delivery device component and method of use | Pending | 26-Oct-2023 | ||
| AU-2024367589-A1 | Medication fluid delivery device component with filling interface | Pending | 26-Oct-2023 | ||
| EP-4798270-A1 | Medication fluid delivery device component with filling interface | Pending | 26-Oct-2023 | ||
| WO-2025088557-A1 | Medication fluid delivery device component with filling interface | Inactive | 26-Oct-2023 | ||
| EP-4511839-A1 | Insulin management for delivering insulin during a fasting period | Pending | 18-Apr-2022 | A61M5/1723 |
Luna Diabetes Signals
Luna Diabetes Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 2468 Ventures | Venture Capital | Minority | ||
| Ascensia Diabetes Care | Corporation | Minority | ||
| Interlock Capital | Venture Capital | Minority | ||
| Serpentine Ventures | Venture Capital | Minority | ||
| Vensana Capital | Venture Capital | Minority |
Luna Diabetes FAQs
-
When was Luna Diabetes founded?
Luna Diabetes was founded in 2020.
-
Where is Luna Diabetes headquartered?
Luna Diabetes is headquartered in Wilmington, DE.
-
What is the size of Luna Diabetes?
Luna Diabetes has 8 total employees.
-
What industry is Luna Diabetes in?
Luna Diabetes’s primary industry is Other Healthcare Technology Systems.
-
Is Luna Diabetes a private or public company?
Luna Diabetes is a Private company.
-
What is the current valuation of Luna Diabetes?
The current valuation of Luna Diabetes is .
-
What is Luna Diabetes’s current revenue?
The current revenue for Luna Diabetes is .
-
How much funding has Luna Diabetes raised over time?
Luna Diabetes has raised $23.6M.
-
Who are Luna Diabetes’s investors?
2468 Ventures, Ascensia Diabetes Care, Interlock Capital, Serpentine Ventures, and Vensana Capital are 5 of 7 investors who have invested in Luna Diabetes.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process